Clinical Trial Record

Return to Clinical Trials

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer


2006-10


2009-08


2009-08


8

Study Overview

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

This is a two-part study. Part I is an observational study. Part II is a randomized clinical trial to see how well medical nutrition therapy works compared with standard care in treating patients with lung cancer, pancreatic cancer, or stage III or stage IV prostate cancer.

In Part II of the study, patients are stratified according to tumor type (pancreatic vs lung vs prostate). Patients are then randomized to 1 of 2 arms. * Arm I (Medical nutrition therapy): intervention with a registered dietitian or nutrition professional. MNT is a cyclical process which includes nutrition assessment, intervention, follow-up, and reassessment. Patients will receive a total of three (3) visits with the dietitian over a six-week period with follow-up during weeks 2-3 and weeks 6-9 based on their treatment schedule. * Arm II (standard care): Standard nutritional care includes the National Cancer Institute's booklet ⋪ting Hints for cancer patients: before, during & after treatment". In both arms, patients' weight, fat free mass, and Patient Generated Subjective Global Assessment Score (PG-SGA) score will be assessed before, during, and after the intervention. The PG-SGA includes a patient report of symptoms and a healthcare professional assessment of medical, metabolic, and physical parameters.

  • Lung Cancer
  • Malnutrition
  • Pancreatic Cancer
  • Prostate Cancer
  • Weight Changes
  • BEHAVIORAL: Medical nutrition therapy
  • BEHAVIORAL: Standard Care
  • CDR0000592862
  • P30CA072720 (U.S. NIH Grant/Contract)
  • 000605 (OTHER Identifier) (OTHER: CINJ)
  • 0220060217 (OTHER Identifier) (OTHER: UMDNJ IRB)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2008-10-08  

2013-11-15  

2023-09-14  

2008-10-08  

2013-11-15  

2023-10-03  

2008-10-09  

2014-01-07  

2023-09  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Supportive Care


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Medical nutrition therapy

Medical nutrition therapy

BEHAVIORAL: Medical nutrition therapy

  • Medical nutrition therapy (MNT) refers to intervention with a registered dietitian or nutrition professional. MNT is a cyclical process which includes nutrition assessment, intervention, follow-up, and reassessment. Patients will receive a total of three
ACTIVE_COMPARATOR: Standard care

Standard care

BEHAVIORAL: Standard Care

  • Standard nutritional care includes the National Cancer Institute's booklet "Eating Hints for cancer patients: before, during & after treatment".
Primary Outcome MeasuresMeasure DescriptionTime Frame
Change in Fat Free Mass (FFM)3 years
Change in Weight3 years
Change in Patient Generated Subjective Global Assessment (PG-SGA) Score at Time of Initial Presentation and Throughout Study3 years
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

    DISEASE CHARACTERISTICS:

  • Diagnosed with one of the following:


  • Pancreatic cancer
  • Lung cancer
  • Stage III or IV prostate cancer
  • Undergoing treatment at The Cancer Institute of New Jersey


  • Are undergoing chemotherapy (part 2 only)
  • Has lost ≥ 5% of their usual body weight in the previous 6 months (part 2 only)

  • PATIENT CHARACTERISTICS:

  • Life expectancy > 60 days
  • Must speak and read English
  • Accessible in person or by phone for completing questionnaires
  • Not pregnant or nursing

  • PRIOR CONCURRENT THERAPY:

  • See Disease Characteristics

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • National Cancer Institute (NCI)

  • PRINCIPAL_INVESTIGATOR: Maureen Huhmann, DCN, RD, CSO, Rutgers Cancer Institute of New Jersey

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available